Compared with the normal controls, NAFLD patients had significantly higher levels of serum TG, LDL, ALT, AST and alkaline phosphatase (AKP) (all P < 0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.